|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu L, Zhong R, Wei S, Yin JY, Xiang H,
Zou L, Chen W, Chen JG, Zheng XW, Huang LJ, et al: Interactions
between genetic variants in the adiponectin, adiponectin receptor 1
and environmental factors on the risk of colorectal cancer. PLoS
One. 6:e273012011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reeves GK, Pirie K, Green J, Bull D and
Beral V: Million Women Study Collaborators: Comparison of the
effects of genetic and environmental risk factors on in situ and
invasive ductal breast cancer. Int J Cancer. 131:930–937. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
Helicobacter pylori. Int J Cancer. 136:487–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin XD, Chen SQ, Qi YL, Zhu JW, Tang Y and
Lin JY: Polymorphism of THBS1 rs1478604 A>G in 5-untranslated
region is associated with lymph node metastasis of gastric cancer
in a Southeast Chinese population. DNA Cell Biol. 31:511–519. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fukumori T, Kanayama HO and Raz A: The
role of galectin-3 in cancer drug resistance. Drug Resist Updat.
10:101–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakahara S, Oka N and Raz A: On the role
of galectin-3 in cancer apoptosis. Apoptosis. 10:267–275. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeong GA, Kim HC, Kim HK and Cho GS:
Perigastric lymph node metastasis from papillary thyroid carcinoma
in a patient with early gastric cancer: The first case report. J
Gastric Cancer. 14:215–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee KB, Park DJ, Choe G, Kim HH, Kim WH
and Lee HS: Protein expression status in mucosal and submucosal
portions of early gastric cancers and their predictive value for
lymph node metastasis. APMIS. 121:926–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang ZM, Wu XT, He T, Da MX, Luo T and
Qian K: Study on association between the expression of galectin- 3
and the peritoneal metastasis in gastric cancer. Zhonghua Wei Chang
Wai Ke Za Zhi. 8:151–154. 2005.(In Chinese). PubMed/NCBI
|
|
14
|
Miyazaki J, Hokari R, Kato S, Tsuzuki Y,
Kawaguchi A, Nagao S, Itoh K and Miura S: Increased expression of
galectin-3 in primary gastric cancer and the metastatic lymph
nodes. Oncol Rep. 9:1307–1312. 2002.PubMed/NCBI
|
|
15
|
Cheong TC, Shin JY and Chun KH: Silencing
of galectin-3 changes the gene expression and augments the
sensitivity of gastric cancer cells to chemotherapeutic agents.
Cancer Sci. 101:94–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Boer RA, Verweij N, van Veldhuisen DJ,
Westra HJ, Bakker SJ, Gansevoort RT, Muller Kobold AC, van Gilst
WH, Franke L, Mateo Leach I and van der Harst P: A genome-wide
association study of circulating galectin-3. PLoS One.
7:e473852012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SJ, Shin JY, Cheong TC, Choi IJ, Lee
YS, Park SH and Chun KH: Galectin-3 germline variant at position
191 enhances nuclear accumulation and activation of β-catenin in
gastric cancer. Clin Exp Metastasis. 28:743–750. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu CY, Chang SK, Wu CS, Tsai WI and Hsu
PN: Galectin-3 gene (LGALS3) +292C allele is a genetic
predisposition factor for rheumatoid arthritis in Taiwan. Clin
Rheumatol. 30:1227–1233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mazurek N, Byrd JC, Sun Y, Ueno S and
Bresalier RS: A galectin-3 sequence polymorphism confers TRAIL
sensitivity to human breast cancer cells. Cancer. 117:4375–4380.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balan V, Nangia-Makker P, Schwartz AG,
Jung YS, Tait L, Hogan V, Raz T, Wang Y, Yang ZQ, Wu GS, et al:
Racial disparity in breast cancer and functional germ line mutation
in galectin-3 (rs4644): A pilot study. Cancer Res. 68:10045–10050.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee YH and Song GG: Genome-wide pathway
analysis in glioma. Neoplasma. 62:230–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song L, Tang JW, Owusu L, Sun MZ, Wu J and
Zhang J: Galectin-3 in cancer. Clin Chim Acta. 431:185–191. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Justenhoven C, Hamann U, Pesch B, Harth V,
Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Brüning T and
Brauch H: ERCC2 genotypes and a corresponding haplotype are linked
with breast cancer risk in a German population. Cancer Epidemiol
Biomarkers Prev. 13:2059–2064. 2004.PubMed/NCBI
|
|
24
|
Wang J, Wang W, Li R, Li Y, Tian G,
Goodman L, Fan W, Zhang J, Li J, Zhang J, et al: The diploid genome
sequence of an Asian individual. Nature. 456:60–65. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z,
He L and Shi Y: A partition-ligation-combination-subdivision EM
algorithm for haplotype inference with multiallelic markers: Update
of the SHEsis. http://analysis.bio-x.cnCell Res. 19:519–523.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi YY and He L: SHEsis, a powerful
software platform for analyses of linkage disequilibrium, haplotype
construction, and genetic association at polymorphism loci. Cell
Res. 15:97–98. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou JP, Yang ZL, Liu DC and Zhou JP:
Expression of galectin 3 and Sambucus nigra agglutinin and their
clinicopathological significance in benign and malignant lesions of
stomach. Zhonghua Wei Chang Wai Ke Za Zhi. 12:297–300. 2009.(In
Chinese). PubMed/NCBI
|
|
28
|
Miyazono K, Ehata S and Koinuma D:
Tumor-promoting functions of transforming growth factor-β in
progression of cancer. Ups J Med Sci. 117:143–152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Webber JP, Spary LK, Sanders AJ, Chowdhury
R, Jiang WG, Steadman R, Wymant J, Jones AT, Kynaston H, Mason MD,
et al: Differentiation of tumour-promoting stromal myofibroblasts
by cancer exosomes. Oncogene. 34:290–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi H, Lu D, Shu Y, Shi W, Lu S and Wang
K: Expression of multidrug resistance-related proteins
p-glycoprotein, glutathione-s-transferases, topoisomerase-II and
lung resistance protein in primary gastric cardiac adenocarcinoma.
Hepatogastroenterology. 55:1530–1536. 2008.PubMed/NCBI
|
|
31
|
Sui H, Zhou S, Wang Y, Liu X, Zhou L, Yin
P, Fan Z and Li Q: COX-2 contributes to P-glycoprotein-mediated
multidrug resistance via phosphorylation of c-Jun at Ser63/73 in
colorectal cancer. Carcinogenesis. 32:667–675. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roy S, Kenny E, Kennedy S, Larkin A,
Ballot J, Perez De Villarreal M, Crown J and O'Driscoll L:
MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in
non-small cell lung cancer. Anticancer Res. 27:1325–1330.
2007.PubMed/NCBI
|
